Survey to assess eligibility for infectious disease clinical trials
Triage Survey for Infectious Disease Eligibility (SWIFT-ID-101)
This study is trying to find out if people are eligible to join clinical trials for infectious diseases like HIV and vaccines by having them fill out a survey about their health and background.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Brooklyn Clinical Research Research network |
| Locations | 1 site (Brooklyn, New York) |
| Trial ID | NCT06492187 on ClinicalTrials.gov |
What this trial studies
SWIFT-ID-101 is an observational survey designed to evaluate potential participants for eligibility in clinical trials focused on infectious diseases, including HIV and vaccination. Participants will undergo an informed consent process overseen by a physician, followed by a survey covering demographics, medical history, and current health status. Additional assessments may include vital signs, blood tests, and other relevant screenings. The study aims to streamline participant selection for future clinical trials in the field of infectious diseases.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who can provide informed consent.
Not a fit: Patients who are pregnant, breastfeeding, or have significant health issues that may affect their safety or study results may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the recruitment process for clinical trials, leading to more effective treatments for infectious diseases.
How similar studies have performed: While this approach is observational and may not have direct precedents, similar eligibility assessments have been used successfully in other clinical trial settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- 1. Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed. 2\. Participant is at least 18 years old. Exclusion Criteria: 1. Participants are pregnant, breast-feeding, or planning to become pregnant. 2. History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results or makes them unsuitable for the study for another reason. 3. Current or recent moderate or severe substance use disorder impacting their ability to follow study related procedures. 4. Reported history of coagulopathy or bleeding disorder considered a contraindication to phlebotomy. 5. Any condition that in the investigator's opinion makes a participant unsuitable for the clinical trial study. 6. Currently employed by Swift Clinical Research Group, Inc. or any of its subsidiaries, including Brooklyn Clinical Research, or a first-degree relative of an employee.
Where this trial is running
Brooklyn, New York
- Brooklyn Clinical Research — Brooklyn, New York, United States (Recruiting)
Study contacts
- Study coordinator: Ammara Mushtaq, MD
- Email: amushtaq@brooklynclinicalresearch.com
- Phone: 9292035879
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.